Publication | Open Access
Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitors
45
Citations
18
References
2019
Year
ICIs were effective in 44 treated NSCLC cases. Our analysis suggests that while ICIs are effective in treating patients, candidates must be carefully selected and cautiously observed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1